Viral delivery of multiple miRNAs promotes retinal ganglion cell survival and functional preservation after optic nerve crush injury.
Adeno-associated virus
Exosomes
Neuroprotection
Optic nerve crush
PTEN
Retinal ganglion cells
miRNA
Journal
Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
20
01
2019
revised:
12
05
2020
accepted:
13
05
2020
pubmed:
24
6
2020
medline:
14
1
2021
entrez:
24
6
2020
Statut:
ppublish
Résumé
Bone marrow mesenchymal stem cell (BMSC)-derived small extracellular vesicles (sEV) but not fibroblast sEV provide retinal ganglion cell (RGC) neuroprotection both in vitro and in vivo, with miRNAs playing an essential role. More than 40 miRNAs were more abundant in BMSC-sEV than in fibroblast-sEV. The purpose of this study was to test the in vitro and in vivo neuroprotective and axogenic properties of six candidate miRNAs (miR-26a, miR-17, miR-30c-2, miR-92a, miR-292, and miR-182) that were more abundant in BMSC-sEV than in fibroblast-sEV. Adeno-associated virus 2 (AAV2) expressing a combination of three of the above candidate miRNAs were added to heterogenous adult rat retinal cultures or intravitreally injected into rat eyes one week before optic nerve crush (ONC) injury. Survival and neuritogenesis of βIII-tubulin
Identifiants
pubmed: 32574667
pii: S0014-4835(20)30330-4
doi: 10.1016/j.exer.2020.108071
pmc: PMC7484142
mid: NIHMS1609137
pii:
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108071Subventions
Organisme : Intramural NIH HHS
ID : Z01 EY000318
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 EY999999
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA EY000318
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
Cell Signal. 2019 Feb;54:179-190
pubmed: 30439502
Stem Cells Transl Med. 2017 Apr;6(4):1273-1285
pubmed: 28198592
PLoS One. 2014 Oct 24;9(10):e110612
pubmed: 25343338
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6091-6104
pubmed: 29204649
Oncotarget. 2015 Sep 29;6(29):27214-26
pubmed: 26318586
J Cell Physiol. 2019 Jun;234(6):8873-8887
pubmed: 30515784
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
FEBS Lett. 2014 Jun 5;588(12):2055-62
pubmed: 24801601
Sci Rep. 2018 Sep 7;8(1):13437
pubmed: 30194392
Annu Rev Pathol. 2009;4:127-50
pubmed: 18767981
Dig Dis Sci. 2014 Jan;59(1):98-107
pubmed: 24026406
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):E6659-E6668
pubmed: 27791035
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):702-714
pubmed: 29392316
Int J Oncol. 2017 Jul;51(1):235-244
pubmed: 28534966
Ann Surg Oncol. 2015 Aug;22(8):2649-55
pubmed: 25515201
Brain. 2018 Sep 1;141(9):2561-2575
pubmed: 30007309
Sci Rep. 2018 Jan 24;8(1):1490
pubmed: 29367685
Brain. 2006 Feb;129(Pt 2):490-502
pubmed: 16339795
Elife. 2016 Mar 14;5:e11903
pubmed: 26974342
Vision Res. 2009 Jan;49(1):115-26
pubmed: 18952118
Stem Cell Res Ther. 2018 Oct 11;9(1):266
pubmed: 30309388
Mol Cell Neurosci. 2002 Sep;21(1):141-57
pubmed: 12359157
Oncol Rep. 2017 Apr;37(4):2513-2521
pubmed: 28260104
Am J Physiol Cell Physiol. 2018 Dec 1;315(6):C839-C849
pubmed: 30183321
Exp Eye Res. 2016 Oct;151:96-106
pubmed: 27523467
Exp Eye Res. 2018 Nov;176:258-265
pubmed: 30237104
Cell Death Dis. 2018 Sep 26;9(10):1007
pubmed: 30258047
Prog Retin Eye Res. 2017 Jul;59:158-177
pubmed: 28465248
Pathol Res Pract. 2017 May;213(5):467-475
pubmed: 28242043
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4357-65
pubmed: 14507880
Cytotherapy. 2016 Apr;18(4):487-96
pubmed: 26897559
Mol Cancer. 2015 Aug 12;14:154
pubmed: 26265437
J Neurocytol. 1996 Feb;25(2):147-70
pubmed: 8699196
Circulation. 2010 Sep 28;122(13):1308-18
pubmed: 20837890
Mol Cancer Res. 2011 Dec;9(12):1732-45
pubmed: 22024689
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Science. 2008 Nov 7;322(5903):963-6
pubmed: 18988856
Am J Physiol Cell Physiol. 2017 Oct 1;313(4):C430-C447
pubmed: 28701356
Mol Ther. 2018 Jan 3;26(1):219-237
pubmed: 28988713
Biomed Pharmacother. 2018 Apr;100:1-7
pubmed: 29421576
Mol Ther. 2008 Oct;16(10):1648-56
pubmed: 18682697
Noncoding RNA Res. 2018 Jul 31;3(3):154-159
pubmed: 30175288
Neurobiol Dis. 2016 Jan;85:99-110
pubmed: 26459109
Mol Cell Neurosci. 2009 Apr;40(4):451-62
pubmed: 19340932
Front Oncol. 2015 Jul 27;5:166
pubmed: 26284192
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2051-9
pubmed: 19933193
Invest Ophthalmol Vis Sci. 2013 Nov 15;54(12):7544-56
pubmed: 24150755
Mol Neurobiol. 2017 May;54(4):2659-2673
pubmed: 26993303
Oncotarget. 2012 Dec;3(12):1653-68
pubmed: 23391506
J Biol Chem. 2010 Jun 25;285(26):20281-90
pubmed: 20404348
Science. 2004 Sep 3;305(5689):1437-41
pubmed: 15284456